CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • CICON16: Translating Science Into Survival

    This Sunday, we are proud to welcome the top international experts in immunology and immunotherapy to New…

    September 24, 2016| Arthur N. Brodsky, PhD
  • CRI Congratulates 2016 Lasker Award Winners

    The Albert and Mary Lasker Foundation announced the 2016 recipients of the prestigious Lasker Awards, and CRI congratulates Charles…

    September 14, 2016| Arthur N. Brodsky, PhD
  • ASCO 2016 Update: Tapping into the Potential of Anti-Tumor T Cells

    Adoptive T cell therapies provide success against some cancers, hope for several others.

    June 17, 2016| Arthur N. Brodsky, PhD
  • ASCO 2016 Update: Immunotherapy & Melanoma: The Path to Progress

    Improved approaches for treating patients with melanoma.

    June 16, 2016| Arthur N. Brodsky, PhD
  • ASCO 2016 Update: Immunotherapy’s Impact in Head & Neck Cancers

    Immunotherapy approaches provide improvements for patients with head and neck cancer.

    June 16, 2016| Arthur N. Brodsky, PhD
  • ASCO 2016 Update: Beyond Checkpoint Blockade: Novel Immunotherapy Strategies for Solid Cancers

    New strategies use alternative ways to promote anti-cancer immunity.

    June 7, 2016| Arthur N. Brodsky, PhD
  • ASCO 2016 Update: Immunotherapy Strategies for Women’s Cancers

    Improving immunotherapy for breast, ovarian, and gynecological cancer patients.

    June 6, 2016| Arthur N. Brodsky, PhD
  • ASCO 2016 Update: Checkpoint Immunotherapy Advances in Solid Cancers

    New insights, approaches to improve outcomes in melanoma, kidney, bladder, and colorectal cancers.

    June 6, 2016| Arthur N. Brodsky, PhD
  • ASCO 2016 Update: Biomarker-Based Strategies

    Molecular clues may help predict patient treatment and outcomes.

    June 6, 2016| Arthur N. Brodsky, PhD

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2026, Cancer Research Institute